NEW YORK (Reuters Health) – Two-thirds of cases of familial hypercholesterolemia (FH) would be missed by relying on array-based genetic
Continue reading »
mypharmacynews.com
Home ยป
NEW YORK (Reuters Health) – Two-thirds of cases of familial hypercholesterolemia (FH) would be missed by relying on array-based genetic
Continue reading »